Trials
Regulations
Contact Us

Welcome to pediculosis.com

Pediculosis.com is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.

btn-readmore

Industry News

      

Scientific News

newsimg-ind

newsimg-sci

22.01.16 | Safety of Oral Ivermectin in Children

New commentary warns of the risks of excessive use of ivermectin for unauthorized groups.

14.09.15 | Xeglyze submitted for FDA approval, commercialisation deal announced

Hatchtech is submitting its Xeglyze lice treatment to the FDA for approval and has signed a commercialisation agreement with Dr. Reddy’s.

08.09.15 | Updated Pediculosis Pipeline insight report

DelveInsight have released an updated report covering the state of the pediculosis treatment pipeline.

28.08.15 | Eden Research license deal with TerpeneTech

Eden Research PLC has agreed a licensing deal with TerpeneTech Ltd granting exclusive use of its encapsulation technologies and other intellectual property for head lice treatments.

16.07.15 | Tyratech update: revenue and funding

Tyratech have announced increased revenues for 2014, and are focussing more of their funding on Vamousse.

06.06.16 | Clinical trials update 2016

A review of head lice clinical trials news in 2016.

06.06.16 | Plant essential oils for combating lice and eggs

A study investigating the chemical composition and the pediculicidal activity of natural essential oils provides evidence for effectiveness against both lice and eggs.

06.06.16 | Prevalence of head lice in Turkey, Iran, Greece and Senegal

Several recent studies shed light on the prevalence of lice infection, and its relationship to socioeconomic factors, across the globe.

26.04.16 | Expansion of the Knockdown Resistance Frequency Map for Head Lice

A new study has produced further information on the spread of lice resistance to pyrethrin-type treatments.

18.03.16 | Ivermectin: Synergistic Activity and Clinical Review

Two new papers on ivermectin provide evidence for synergistic anti-lice activity when combined with antibiotics.

morenews-ind.png morenews-sci.png
  • Regulatory News
  • Pediculosis.com: The world's only specialist website for the head lice industry
  • Licecomb Engineering
  • Company News
  • Scientific News

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved